These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38558281)

  • 21. Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database.
    Stadler M; Bollow E; Fritsch M; Kerner W; Schuetz-Fuhrmann I; Krakow D; Merger S; Riedl M; Jehle P; Holl RW;
    Diabetes Obes Metab; 2017 Aug; 19(8):1171-1178. PubMed ID: 28256088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes.
    Alexopoulos AS; Parish A; Olsen M; Batch BC; Moylan CA; Crowley MJ
    Endocr Pract; 2024 Jul; 30(7):663-669. PubMed ID: 38697305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alanine aminotransferase elevation varies by ethnicity among Asian and Pacific Islander children with overweight or obesity.
    Lee C; Schwimmer JB; Gunderson EP; Goyal NP; Darbinian JA; Greenspan LC; Lo JC
    Pediatr Obes; 2024 Jun; 19(6):e13110. PubMed ID: 38444225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.
    Nagl K; Hermann JM; Plamper M; Schröder C; Dost A; Kordonouri O; Rami-Merhar B; Holl RW
    Pediatr Diabetes; 2017 Sep; 18(6):428-434. PubMed ID: 27416952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes.
    Della Pepa G; Lupoli R; Masulli M; Boccia R; De Angelis R; Gianfrancesco S; Piccolo R; Rainone C; Rivellese AA; Annuzzi G; Bozzetto L
    J Endocrinol Invest; 2024 Sep; 47(9):2371-2378. PubMed ID: 38498227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.
    Fukuda T; Okamoto T; Fukaishi T; Kawakami A; Tanaka M; Yamada T; Monzen K
    Front Endocrinol (Lausanne); 2024; 15():1392280. PubMed ID: 38779448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany.
    Maahs DM; Hermann JM; Holman N; Foster NC; Kapellen TM; Allgrove J; Schatz DA; Hofer SE; Campbell F; Steigleder-Schweiger C; Beck RW; Warner JT; Holl RW;
    Diabetes Care; 2015 Oct; 38(10):1876-82. PubMed ID: 26283737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus.
    Nwosu BU; Maranda L
    PLoS One; 2014; 9(6):e99646. PubMed ID: 24918447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12-79 years.
    Shen TH; Wu CH; Lee YW; Chang CC
    Eur J Gastroenterol Hepatol; 2024 May; 36(5):636-645. PubMed ID: 38477858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
    Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
    J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood maltreatment and risk of metabolic dysfunction-associated steatotic liver disease - Evidence of sex-specific associations in the general population.
    Siewert-Markus U; Ittermann T; Klinger-König J; Grabe HJ; Stracke S; Völzke H; Targher G; Dörr M; Markus MRP; Töpfer P
    J Psychosom Res; 2024 Aug; 183():111829. PubMed ID: 38896985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
    Song Z; Miao X; Xie X; Tang G; Deng J; Hu M; Liu S; Leng S
    Lipids Health Dis; 2024 May; 23(1):141. PubMed ID: 38760825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States.
    DuBose SN; Hermann JM; Tamborlane WV; Beck RW; Dost A; DiMeglio LA; Schwab KO; Holl RW; Hofer SE; Maahs DM;
    J Pediatr; 2015 Sep; 167(3):627-32.e1-4. PubMed ID: 26164381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma in children and adolescents with type 1 diabetes in Germany and Austria: Frequency and metabolic control.
    Hörtenhuber T; Kiess W; Fröhlich-Reiterer E; Raile K; Stachow R; Bollow E; Rami-Merhar B; Holl RW;
    Pediatr Diabetes; 2018 Jun; 19(4):727-732. PubMed ID: 29218837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes.
    Zhu N; Song Y; Zhang C; Wang K; Han J
    Front Med (Lausanne); 2023; 10():1294425. PubMed ID: 38020132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes.
    Reinauer C; Reinehr T; Baechle C; Karges B; Seyfarth J; Foertsch K; Schebek M; Woelfle J; Roden M; Holl RW; Rosenbauer J; Meissner T
    Horm Res Paediatr; 2018; 89(2):73-81. PubMed ID: 29207397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular risk factors in children, adolescents, and young adults with type 1 diabetes complicated by celiac disease: results from the DPV initiative.
    Warncke K; Liptay S; Fröhlich-Reiterer E; Scheuing N; Schebek M; Wolf J; Rohrer TR; Meissner T; Holl RW
    Pediatr Diabetes; 2016 May; 17(3):191-8. PubMed ID: 25677756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity.
    Garibay-Nieto N; Pedraza-Escudero K; Omaña-Guzmán I; Garcés-Hernández MJ; Villanueva-Ortega E; Flores-Torres M; Pérez-Hernández JL; León-Hernández M; Laresgoiti-Servitje E; Palacios-González B; López-Alvarenga JC; Lisker-Melman M; Vadillo-Ortega F
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893503
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
    Tittel SR; Sondern KM; Weyer M; Poeplau T; Sauer BM; Schebek M; Ludwig KH; Hammer F; Fröhlich-Reiterer E; Holl RW;
    Acta Diabetol; 2020 Oct; 57(10):1245-1253. PubMed ID: 32488499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies.
    van Son KC; Te Nijenhuis-Noort LC; Boone SC; Mook-Kanamori DO; Holleboom AG; Roos PR; Lamb HJ; Alblas G; Coenraad MJ; Rosendaal FR; de Mutsert R; Tushuizen ME
    Medicine (Baltimore); 2024 Jan; 103(1):e34934. PubMed ID: 38181294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.